Under hypoxic conditions, CD45+ EPCs can regulate lipid metabolism and enhance energy metabolism in lymphoma cells via the AMPK–ACC–CPT1A pathway, which further promotes cell proliferation and inhibits apoptosis in lymphoma cells. Here, PTPRC is linked to lymphoma.